Stocklytics Platform
Asset logo for symbol LIVN
LivaNova PLC
LIVN64
$41.86arrow_drop_down2.66%-$1.14
Asset logo for symbol LIVN
LIVN64

$41.86

arrow_drop_down2.66%

Income Statement (LIVN)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
EBIT$72.24M$60.31M$37.12M-$18.30M-$75.51M
EBITDA$84.83M$73.44M$49.41M-$5.16M-$59.63M
gross Profit$219.40M$225.26M$220.36M$210.59M$190.20M
NET Income$55.89M$32.95M$16.33M-$41.94M$16.33M
total Revenue$321.80M$318.12M$318.57M$294.91M$310.10M

Balance Sheet (LIVN)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
cash Equivalents-----
net Debt$238.80M$333.42M$44.40M$61.07M$62.53M
stockholders Equity$1.32B$1.31B$1.24B$1.22B$1.27B
total Assets$2.50B$2.52B$2.45B$2.45B$2.42B
total Debt$667.70M$679.79M$677.52M$676.75M$640.40M
total Liabilities$1.18B$1.21B$1.21B$1.23B$1.15B

Cash Flow (LIVN)

itemDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
financing Cash Flow-$3.44M-$3.28M-$11.87M$37.14M-$5.01M
free Cash Flow$68.30M$32.84M$31.20M$3.58M$41.03M
investing Cash Flow-----
operating Cash Flow$78.70M$50.99M$43.35M$9.98M$53.95M

LivaNova PLC (LIVN) Financials

LivaNova PLC is a global medical technology company that develops and manufactures innovative solutions for the treatment of cardiovascular diseases and chronic pain. The company's income statement reflects its financial performance over a specific period. It shows the revenue generated from its operations, as well as the expenses incurred in running the business. LivaNova's income statement also includes its gross profit, which is the difference between its total revenue and the cost of goods sold. The net income from stockholders represents the company's profit after accounting for all expenses and taxes.
One important metric to assess LivaNova's profitability is its EBIT (earnings before interest and taxes). EBIT measures the company's operating profitability by excluding interest and tax expenses. Another relevant metric is EBITDA (earnings before interest, taxes, depreciation, and amortization). EBITDA provides a more comprehensive view of LivaNova's operating performance by excluding non-cash expenses like depreciation and amortization. These metrics help investors evaluate the company's ability to generate profits from its core operations.
LivaNova's total revenue represents the sum of all the revenue generated by the company, including sales of its medical devices and other products or services. It reflects the company's ability to attract customers and grow its business. The balance sheet provides a snapshot of LivaNova's financial position at a specific point in time. It includes information about the company's assets, liabilities, and stockholders' equity. Cash equivalents represent highly liquid investments that can be readily converted into cash, such as short-term marketable securities.
Net debt refers to the company's total debt minus its cash and cash equivalents. It gives an indication of LivaNova's financial leverage and its ability to manage its debt obligations. Stockholders' equity represents the amount of capital contributed by shareholders and accumulated profits. It gives investors an idea of the value of their ownership in the company. Total assets represent the company's investments in its operations, including physical assets, intellectual property, and investments in other companies.
Total debt includes both short-term and long-term borrowings that LivaNova has incurred. It reflects the company's debt obligations and its ability to meet its financial obligations. Total liabilities represent the company's obligations to third parties, including debts, payables, and other liabilities. Cash flow is a measure of LivaNova's ability to generate cash from its operations. It includes cash inflows and outflows from various activities, such as operating, investing, and financing.
Financing cash flow represents the cash generated or used in financing activities, such as issuing or repurchasing stock, paying dividends, or obtaining or repaying debt. Free cash flow measures the cash available for distribution to investors after deducting capital expenditures and other cash outflows. It is an indicator of LivaNova's financial strength and its ability to invest in growth opportunities. Investing cash flow reflects the cash used or generated from buying or selling assets, making investments, or acquiring or divesting subsidiaries.
Operating cash flow shows the cash generated or used in the company's core operations. It excludes cash flows from financing and investing activities. LivaNova's financials provide valuable insights into its performance, profitability, and financial position. Investors and analysts can use these metrics to assess the company's financial health and make informed investment decisions.
add LivaNova PLC to watchlist

Keep an eye on LivaNova PLC

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level